ELENA TIMOFTI: Open Payments
NPI 1275370512 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Amgen Inc. | 4 | $64 |
| Kestra Medical Technology Services, Inc. | 2 | $57 |
| SCPHARMACEUTICALS INC. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| CVRx, Inc. | 1 | $25 |
| AtriCure, Inc. | 1 | $23 |
Products named: REPATHA, Assure WCD, LEQVIO, FUROSCIX, VERQUVO, Barostim Neo System, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, ENTRESTO.
Industry payments across FL — which companies pay providers there.
